Akerna Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Akerna.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Software croissance des bénéfices	17.3%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

Akerna Corp.'s (NASDAQ:KERN) Revenues Are Not Doing Enough For Some Investors

Oct 19

Akerna announces $5M private placement of convertible redeemable preferred stock

Oct 03

Akerna Corp. (NASDAQ:KERN) Analysts Just Slashed This Year's Revenue Estimates By 12%

Aug 14

The Akerna (NASDAQ:KERN) Share Price Has Gained 14% And Shareholders Are Hoping For More

Mar 10

Here's What Akerna Corp.'s (NASDAQ:KERN) Shareholder Ownership Structure Looks Like

Feb 03

Integrate Akerna Into Your Cannabis Investment Basket

Feb 02

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Akerna n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:KERN - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
9/30/2023	10	-21	-7	-6	N/A
6/30/2023	11	-24	-10	-8	N/A
3/31/2023	12	-41	-14	-10	N/A
12/31/2022	14	-60	-15	-11	N/A
9/30/2022	14	-64	-19	-14	N/A
6/30/2022	16	-60	-17	-12	N/A
3/31/2022	18	-46	-16	-10	N/A
12/31/2021	18	-31	-14	-8	N/A
9/30/2021	18	-26	-14	-10	N/A
6/30/2021	17	-29	-16	-12	N/A
3/31/2021	15	-28	-19	-15	N/A
12/31/2020	14	-26	-21	-17	N/A
9/30/2020	13	-18	-19	-15	N/A
6/30/2020	13	-14	-18	-14	N/A
3/31/2020	13	-18	-14	-14	N/A
12/31/2019	12	-15	-13	-12	N/A
9/30/2019	12	-13	-12	-11	N/A
6/30/2019	11	-12	-9	-9	N/A
3/31/2019	10	-7	-7	-7	N/A
12/31/2018	10	-4	-4	-4	N/A
9/30/2018	10	-3	-3	-3	N/A
6/30/2018	10	-2	-4	-4	N/A
6/30/2017	6	-7	N/A	-5	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de KERN est supérieure au taux d'épargne ( 2.3% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de KERN devraient croître plus rapidement que le marché US

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de KERN devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de KERN devraient croître plus rapidement que le marché US.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de KERN devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de KERN devrait être élevé dans 3 ans

Akerna Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Consensus revenue estimates fall by 44%

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$3.13

Consensus forecasts updated

Recent updates

Akerna Corp.(NasdaqCM:KERN) dropped from NASDAQ Composite Index

Akerna Announces Special Meeting to Vote on Gryphon Digital Merger

Akerna Corp., Annual General Meeting, Dec 28, 2023

Insufficient new directors

Akerna Corp. Announces Resignation of Barry Fishman as Director

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Akerna Corp.'s (NASDAQ:KERN) Revenues Are Not Doing Enough For Some Investors

Akerna Receives a Determination Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Akerna Corp. announced that it expects to receive $0.5 million in funding from MJ Bridge Co., Inc.

First quarter 2023 earnings released: US$0.48 loss per share (vs US$13.89 loss in 1Q 2022)

Consensus revenue estimates fall by 44%

Full year 2022 earnings released: US$20.35 loss per share (vs US$24.44 loss in FY 2021)

Akerna Regains Compliance with NASDAQ Continued Listing Requirements

Gryphon Digital Mining, Inc. entered into an agreement to acquire Akerna Corp. (NasdaqCM:KERN) in a reverse merger transaction.

POSaBIT Systems Corporation agreed to a acquire MJ Platform, Leaf Data Systems LLC, and Ample Organics Inc. from Akerna Corp. for $4 million.

365 Holdco LLC acquired 365 Cannabis from Akerna Corp. (NasdaqCM:KERN) for $2.8 million.

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Akerna Corp. Announces Intent to Effect Reverse Stock Split

Akerna Corp. announced that it has received $5 million in funding

Akerna Corp. announced that it expects to receive $5 million in funding

Akerna announces $5M private placement of convertible redeemable preferred stock

Akerna Corp. has completed a Follow-on Equity Offering in the amount of $23.1 million.

Akerna Corp. has completed a Follow-on Equity Offering in the amount of $23.1 million.

Consensus forecasts updated

Akerna Corp. (NASDAQ:KERN) Analysts Just Slashed This Year's Revenue Estimates By 12%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Akerna Corp. Reports Impairment of Long-Lived Assets for the Second Quarter Ended June 30, 2022

Akerna GAAP EPS of -$0.83, revenue of $6.1M

Akerna Corp. to Report Q2, 2022 Results on Aug 10, 2022

High number of new directors

Akerna Corp. Appoints Larry Dean Ditto as Chief Financial Officer

Akerna Corp. has completed a Composite Units Offering in the amount of $9.99859 million.

Akerna Corp. has completed a Composite Units Offering in the amount of $9.99859 million.

Akerna slashes 48%, prices $10M offering

Akerna Corp., Annual General Meeting, May 25, 2022

Akerna Corp. Announces Management Changes

Consensus forecasts updated

Akerna Corp., Annual General Meeting, May 23, 2022

Akerna Corp. Reports Impairment of Long-Lived Assets for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to US$3.13

High number of new and inexperienced directors

Akerna Corp., Annual General Meeting, May 13, 2022

Consensus forecasts updated

Price target decreased to US$6.83

Akerna Corp.: Pot Industry Enabler

Independent Director recently bought US$346k worth of stock

Akerna Corp. (NasdaqCM:KERN) signed an agreement to acquire 365 Cannabis for $25 million.

Is Akerna (NASDAQ:KERN) Using Debt In A Risky Way?

Consensus forecasts updated

Price target decreased to US$7.83

Akerna Corp.(NasdaqCM:KERN) dropped from Russell 3000E Index

Akerna Corp. announced delayed 10-Q filing

First quarter 2021 earnings released: US$0.28 loss per share (vs US$0.38 loss in 1Q 2020)

Is Akerna (NASDAQ:KERN) Using Debt Sensibly?

Second quarter 2021 earnings released: US$0.67 loss per share (vs US$0.40 loss in 2Q 2020)

Akerna Corp. Announces Impairment of Long-Lived Assets for the Second Quarter Ended December 31, 2020

Akerna Corp., Annual General Meeting, May 27, 2021

Akerna Corp. (NasdaqCM:KERN) signed an agreement to acquire Viridian Sciences for $ 6 million.

The Akerna (NASDAQ:KERN) Share Price Has Gained 14% And Shareholders Are Hoping For More

New 90-day high: US$7.09

Here's What Akerna Corp.'s (NASDAQ:KERN) Shareholder Ownership Structure Looks Like

Integrate Akerna Into Your Cannabis Investment Basket

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action